Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Clinical Oncology: Case Reports
Joo Yeoun Park Author
Subjects of specialization
Affiliation
cancer, cancer oncology, Carcinogenesis
McGill Centre for Translational Research in Cancer, Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada, U.S.A.
Biography
Dr. Joo Yeoun Park is working as scientist and professor at McGill Centre for Translational Research in Cancer, Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada, U.S.A. . The author has specalization in cancer, cancer oncology, chemotherapy, Carcinogenesis, Chemotherapy
Publications
Case Report Open Access
Orally Administered Multiple Dose Saltikva (Salmonella-IL2) in Conjunction with Folfirinox in a Patient with Stage IV Pancreatic Cancer: A Case Report
Author(s): Gerald Batist, Joo Yeoun Park, Jeremy Drees, Takashi Kangas and Daniel Saltzman* (USA)
Compassionate use of Saltikva was sought for a patient with stage 4, metastatic pancreatic cancer. Approval was granted for an n=1 multiple dose (every 2 week) trial with concomitant FOLFIRINOX. Now, at 15 months, this patient has not experienced any toxicity to Saltikva, continues therapy, has normalized CA19-9 levels, maintained her immunologic cell populations despite cytotoxic chemotherapy, demonstrated a strong NK cell response, and has a radiologic regression of metastatic tumor burden with a complete absence of tumor activity by PET scan.
... view more»Google Scholars / Researchers Sites
